Transformation of an active pharmaceutical ingredient upon high-energy milling: A process-induced disorder in Biclotymol

Int J Pharm. 2016 Feb 29;499(1-2):67-73. doi: 10.1016/j.ijpharm.2015.12.032. Epub 2015 Dec 17.

Abstract

This study investigates for the first time the thermodynamic changes of Biclotymol upon high-energy milling at various levels of temperature above and below its glass transition temperature (Tg). Investigations have been carried out by temperature modulated differential scanning calorimetry (TM-DSC) and X-ray powder diffraction (XRPD). Results indicate that Biclotymol undergoes a solid-state amorphization upon milling at Tg-45 °C. It is shown that recrystallization of amorphous milled Biclotymol occurs below the glass transition temperature of Biclotymol (Tg=20 °C). This displays molecular mobility differences between milled Biclotymol and quenched liquid. A systematic study at several milling temperatures is performed and the implication of Tg in the solid-state transformations generally observed upon milling is discussed. Influence of analysis temperature with respect to interpretation of results was investigated. Finally, it is shown that co-milling Biclotymol with only 20 wt% of amorphous PVP allows a stable amorphous dispersion during at least 5 months of storage.

Keywords: Amorphous; Biclotymol; Biclotymol (PubChem CID71878); Glass transition; Milling; Pharmaceuticals; Polyvinylpyrrolidone; Polyvinylpyrrolidone (PubChem CID6917); Stability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calorimetry, Differential Scanning
  • Chemistry, Pharmaceutical / methods*
  • Drug Stability
  • Drug Storage
  • Phenols / administration & dosage
  • Phenols / chemistry*
  • Temperature
  • Thermodynamics*
  • Transition Temperature
  • X-Ray Diffraction

Substances

  • Phenols
  • 2,2-methylenebis(4-chloro-3-methyl-isopropylphenol)